risk stratification in nmibc and classification of low-grade, intermediate-risk disease
Published 9 months ago • 352 plays • Length 10:12Download video MP4
Download video MP3
Similar videos
-
11:44
bladder cancer risk stratification: moving from the old to the new
-
4:28
very high risk non-muscle-invasive bladder cancer (nmibc) in the current landscape of nmibc
-
1:01:10
urowebinar: patient stratification and risk related treatment of nmibc
-
57:13
risk stratified management of nmibc - empire urology lecture series
-
26:18
controversies in non-muscle invasive bladder cancer (nmibc): guidelines and beyond 2023
-
26:20
management of non-muscle invasive bladder cancer
-
10:00
bcg treatment for non-muscle invasive bladder cancer
-
42:48
bladder cancer
-
27:09
detail: chemotherapy & immunotherapy (bcg) for non muscle invasive bladder cancer
-
6:49
the evolving landscape in the management of high-risk non-muscle-invasive bladder cancer
-
15:34
therapy for high risk nmibc
-
40:36
treatment paradigms for intermediate and high-risk non-muscle invasive bladder cancer
-
14:18
barriers to clinical trials for non-muscle invasive bladder cancer
-
15:29
understanding types and grades of non-muscle invasive bladder cancer
-
10:44
earlier use of immune checkpoint inhibitors to adjuvant and non muscle invasive bladder cancer
-
14:37
controversies in nmibc: guidelines and beyond
-
51:36
treatment of high risk nmibc in era of bcg shortage - empire urology lecture series
-
5:14
erdafitinib demonstrates efficacy in intermediate-risk nmibc with fgfr alterations
-
21:37
non-muscle invasive bladder cancer: guidelines-based approach
-
19:16
diagnosis & treatment of non-muscle invasive bladder cancer: aua/suo guidelines
-
15:36
difficult issues in non muscle invasive bladder cancer
-
35:48
ncis isos 2021 - challenges and new options in the management of non-muscle invasive bladder cancer